Your browser doesn't support javascript.
loading
Galectin-3 inhibition suppresses drug resistance, motility, invasion and angiogenic potential in ovarian cancer.
Mirandola, Leonardo; Yu, Yuefei; Cannon, Martin J; Jenkins, Marjorie R; Rahman, Rakhshanda L; Nguyen, Diane D; Grizzi, Fabio; Cobos, Everardo; Figueroa, Jose A; Chiriva-Internati, Maurizio.
Afiliação
  • Mirandola L; Department of Internal Medicine at the Division of Hematology & Oncology & Oncology, The Southwest Cancer Treatment and Research Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Laura W Bush Institute for Women's Health and Center for Women's Health and Gender-Based Me
  • Yu Y; Department of Internal Medicine at the Division of Hematology & Oncology & Oncology, The Southwest Cancer Treatment and Research Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA.
  • Cannon MJ; University of Arkansas for Medical Sciences, Department of Obstetrics and Gynecology, Little Rock, AR, USA.
  • Jenkins MR; Laura W Bush Institute for Women's Health and Center for Women's Health and Gender-Based Medicine, Amarillo, TX, USA.
  • Rahman RL; Division of Surgical Oncology, Texas Tech University Medical Center, Amarillo, TX, USA.
  • Nguyen DD; Department of Internal Medicine at the Division of Hematology & Oncology & Oncology, The Southwest Cancer Treatment and Research Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Kiromic, Inc., Lubbock, TX, USA.
  • Grizzi F; Humanitas Clinical and Research Center, Milano, Italy.
  • Cobos E; Department of Internal Medicine at the Division of Hematology & Oncology & Oncology, The Southwest Cancer Treatment and Research Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Laura W Bush Institute for Women's Health and Center for Women's Health and Gender-Based Me
  • Figueroa JA; Department of Internal Medicine at the Division of Hematology & Oncology & Oncology, The Southwest Cancer Treatment and Research Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Kiromic, Inc., Lubbock, TX, USA.
  • Chiriva-Internati M; Department of Internal Medicine at the Division of Hematology & Oncology & Oncology, The Southwest Cancer Treatment and Research Center, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Laura W Bush Institute for Women's Health and Center for Women's Health and Gender-Based Me
Gynecol Oncol ; 135(3): 573-9, 2014 Dec.
Article em En | MEDLINE | ID: mdl-25284038
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Galectina 3 Tipo de estudo: Screening_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2014 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Galectina 3 Tipo de estudo: Screening_studies Limite: Female / Humans Idioma: En Revista: Gynecol Oncol Ano de publicação: 2014 Tipo de documento: Article